Strata Oncology: Funding, Investors & Team (Oct 2026)
Strata Oncology is a precision oncology company dedicated to transforming cancer care by expanding patient access to precision medicine clinical trials and accelerating drug approval. Strata's national precision oncology platform serves the needs of patients, providers and drug developers by providing a link from patient screening to streamlined enrollment in mutation-matched clinical trials. Follow us on Twitter @StrataOncology.
Strata Oncology has raised $90.0M across 1 funding round on record, the most recent a Series C of $90.0M announced in Jul 2021.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Strata Oncology Company Profile and Key Stats
Latest funding round on record: Jul 2021.
Strata Oncology Funding Rounds
Strata Oncology Founders and Leadership Team
Contact details for the Strata Oncology team: 1 of 1 has an email address on file.
Start 14-day free trial →Strata Oncology Funding Compared to Other Biotechnology Startups
Strata Oncology's latest round of $90.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Strata Oncology in Biotechnology and Ann Arbor
Companies Similar to Strata Oncology
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Strata Oncology Funding FAQs
What does Strata Oncology do?
Strata Oncology is a precision oncology company dedicated to transforming cancer care by expanding patient access to precision medicine clinical trials and accelerating drug approval. Strata's national precision oncology platform serves the needs of patients, providers and drug developers by providing a link from patient screening to streamlined enrollment in mutation-matched clinical trials. Follow us on Twitter @StrataOncology.
How much funding has Strata Oncology raised?
Strata Oncology has raised $90.0M across 1 round on record. The most recent is a Series C of $90.0M announced in Jul 2021.
When did Strata Oncology last raise funding?
Strata Oncology's most recent funding round on record is a Series C of $90.0M, announced in Jul 2021.
Who is the CEO of Strata Oncology?
Dan Rhodes is listed as CEO at Strata Oncology.
Where is Strata Oncology headquartered?
Strata Oncology is based in Ann Arbor, Michigan, United States.
How many employees does Strata Oncology have?
Strata Oncology is in the 51-100 employee band.
How does Strata Oncology's funding compare to other Biotechnology startups?
Strata Oncology's latest round of $90.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Strata Oncology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Strata Oncology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.